LEGFLOW® RX/OTW

Paclitaxel Releasing Peripheral Balloon

Dilatation Catheter

 

Powered by SAFEPAX® Technology:

The 3rd generation, unique paclitaxel matrix system with the highest coating stability on the market

 

Excellent Deliverability:

The elastic coating ensures smooth and easy crossing of complex anatomies and the optimised PTA hypotube shaft secures kink resistance and pushability

 

No Compromise:

Unsurpassed range of paclitaxel releasing peripheral balloon dilatation catheters

SAFEPAX®:

the Paclitaxel Matrix of the Future

With SAFEPAX® CARDIONOVUM is leading the way in matrix technology. SAFEPAX® is a third-generation paclitaxel balloon matrix coating, developed exclusively for the CARDIONOVUM family of DCBs for maximal safety and optimised drug delivery.

 

Locally delivered 3 μg/mm2 paclitaxel dose for consistent inhibition of neointimal proliferation without compromising safety.

 

Virtually loss-less matrix for improved homogeneity of drug transfer

 

 Proprietary ammonium salt solution excipient

■ Hydrophobic during catheter tracking

Minimal drug loss during introduction to target site

■ Lipophilic when inflated

Reliable drug release and transfer into the vessel wall

■ Elastic

Low surface friction; consistent smoothness and minimised risk of dissection

 

Comparison between the virtually loss-less SAFEPAX® DCB PTX Balloon Coating (top) and a first-generation DCB coating (bottom)

 

LEGFLOW® RX/OTW

Reliable Complex Lesion Crossing with all Benefits from SAFEPAX® Matrix

LEGFLOW® was developed to facilitate complex lesion crossing and deliver the advantages of the third-generation virtually loss-less SAFEPAX® matrix.

 

The catheter design combined with the high elasticity of the SAFEPAX® matrix ensures low stickness, kink resistance and smooth pushability.

 

Guidewire friction is further reduced by an extruded guidewire lumen and an atraumatic tip. The PTA balloon was specifically designed for maximal synergy with the unique SAFEPAX® matrix.

 

The Result:

Unsurpassed ease of handling and safety, and precise drug delivery

 

Peter Goverde, Antwerp BE: “LEGFLOWs design, wide portfolio and different platforms makes it an ideal DCB to treat arteries from iliac to tibial level.”

Roberto Ferraresi, Bergamo IT:

”Onlywith the Legflow 0.014 (OTW/RX) catheter I can treat plantar arch disease patients.”

Download Product Brochure .pdf  4.0 MB

News & Announcements

Terms & Conditions

Privicy Policy

KVKK

Contact

Endomed Grup Medikal San. ve Tic.  A.Ş.

Koru Mah. Ihlamur Cad. No:2 / 4 Çankaya Ankara Turkey

PHONE: +90 312 291 5143

FAX: +90 312 437 8112

email: info@endomedgrup.com

 

LOCATION

Endomed Grup Medikal © 2022